BGB-A333

· BeiGene

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for BGB-A333, covering 2021-11-09 to 2021-11-09. Get the full timeline:

Most recent: Clinical Trial Update: Study of BGB-A333 Alone and in Combination With Tislelizumab in Advanced Solid Tumors [Phase 1, Phase 2]